MARKET

MDCLF

MDCLF

MEDINCELL
EXMKT
9.70
NaN%
Closed 09:30 10/26 EDT
OPEN
--
PREV CLOSE
14.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
9.70
52 WEEK LOW
9.70
MARKET CAP
348.23M
P/E (TTM)
-8.9649
1D
5D
1M
3M
1Y
5Y
1D
MedinCell downgraded to Hold from Buy at Kepler Cheuvreux
TipRanks · 10/14 20:35
MedinCell Delays Half-Year 2026 Earnings Release by One Day
TipRanks · 10/14 16:43
MedinCell Bolsters Finances With €41.8 Million in Non-Dilutive Funding
TipRanks · 10/13 16:37
Leerink Partners Sticks to Their Buy Rating for MedinCell SA (MEDCL)
TipRanks · 10/13 05:45
MedinCell Halts Euronext Trading Ahead of Market-Sensitive Announcement
TipRanks · 10/09 14:03
Medincell Gains Second FDA-Approved Antipsychotic as WELTRUZA Strengthens Long-Acting Injectable Strategy
TipRanks · 10/09 12:10
Medincell Shares Suspended on Euronext as Long-Acting Injectable Portfolio Advances
TipRanks · 10/09 08:03
MedinCell Updates Share Capital and Voting Rights as BEPO Platform Gains Global Traction
TipRanks · 10/05 16:53
More
About MDCLF
Medincell SA is a France-based manufacturer of biological products and pharmaceutical preparations. The Company is focused on the development of therapeutic solutions with worldwide access. The Company works on both for-profit and non-profit projects, in collaboration with partners ranging from pharmaceutical corporations to physicians, from biotechnology firms to academics and foundations. Its range of products consists of three products in development phase: mdc-IRM, a subcutaneous injection in phase III clinical study for the treatment of schizophrenia; mdc-CWM, an intra-articular injection in phase II clinical study for the treatment of post-surgical pain and inflammation; mdc-TJK, a subcutaneous injection for the treatment of schizophrenia, as well as a number of other products that are in the research phase, such as mdc-WWM, which is a subcutaneous injection for contraception, and mdc-ELK, a subcutaneous injection for the treatment of depression, among others.

Webull offers Medincell SA stock information, including EXMKT: MDCLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDCLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDCLF stock methods without spending real money on the virtual paper trading platform.